TPX-0005, a novel ALK/ROS1/TRK inhibitor, effectively inhibited a broad spectrum of mutations including solvent front ALK G1202R, ROS1 G2032R and TRKA G595R mutants von Cui, J.J, Zhai, D, Deng, W, Rogers, E, Huang, Z, Whitten, J, Li, Y

Volltext

Development of a stage-structured process-based predator–prey model to analyse biological control of cotton aphid, Aphis gossypii, by the sevenspot ladybeetle, Coccinella septempun... von Xia, J.Y., Wang, J., Cui, J.J., Leffelaar, P.A., Rabbinge, R., van der Werf, W.

Volltext

EP.03F.01 Modeling the Relationship of Clinical Safety Profile of EGFR Inhibitors with Wild-Type EGFR Inhibition in Cellular Model von Zhou, J., Deng, W., Jiang, P., Zimmerman, Z., Liptak, V., Cui, J.J.

Volltext

Research on the Influences of Private Equity on Small and Medium-sized Enterprises in Big Data Era von J.J. Cui

Volltext

444PD - Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1/TRK fusion-positive solid tumors (TRIDENT-1 study) von Drilon, A., Cho, B.C., Kim, D.-W., Lee, J., Lin, J.J., Zhu, V., Camidge, R.D., Stopatschinskaja, S., Cui, J.J., Hyman, D.M., Ou, S.-H., Shaw, A.T., Doebele, R.C.

Volltext

Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1/TRK fusion-positive solid tumors (TRIDENT-1 study) von Drilon, A., Cho, B.C., Kim, D.-W., Lee, J., Lin, J.J., Zhu, V., Camidge, R.D., Stopatschinskaja, S., Cui, J.J., Hyman, D.M., Ou, S.-H., Shaw, A.T., Doebele, R.C.

Volltext

Triple MET/SRC/PIM inhibition in MET addicted tumors von Attili, I., Bonanno, L., Bracht, J.P., Berenguer, J., Codony-Servat, C., Codony-Servat, J., Ito, M., Conte, P.F., Cui, J.J., Karachaliou, N., Rosell, R.

Volltext

1967P - Triple MET/SRC/PIM inhibition in MET addicted tumors von Attili, I., Bonanno, L., Bracht, J.P., Berenguer, J., Codony-Servat, C., Codony-Servat, J., Ito, M., Conte, P.F., Cui, J.J., Karachaliou, N., Rosell, R.

Volltext

75 - TPX-0005, a novel ALK/ROS1/TRK inhibitor, effectively inhibited a broad spectrum of mutations including solvent front ALK G1202R, ROS1 G2032R and TRKA G595R mutants von Cui, J.J., Zhai, D., Deng, W., Rogers, E., Huang, Z., Whitten, J., Li, Y.

Volltext

506P - TPX-0046 is a novel and potent RET/SRC inhibitor for RET-driven cancers von Drilon, A., Rogers, E., Zhai, D., Deng, W., Zhang, X., Lee, D., Ung, J., Whitten, J., Zhang, H., Liu, J., Hu, T., Zhuang, H., Lu, Y., Huang, Z., Graber, A., Zimmerman, Z., Xin, R., Cui, J.J., Subbiah, V.

Volltext

TPX-0046 is a novel and potent RET/SRC inhibitor for RET-driven cancers von Drilon, A., Rogers, E., Zhai, D., Deng, W., Zhang, X., Lee, D., Ung, J., Whitten, J., Zhang, H., Liu, J., Hu, T., Zhuang, H., Lu, Y., Huang, Z., Graber, A., Zimmerman, Z., Xin, R., Cui, J.J., Subbiah, V.

Volltext

Search for the semi-leptonic decays Λ c + → Λ π + π − e + ν e and Λ c + → p K S 0 π − e + ν e von Ablikim, M., Achasov, M.N., Adlarson, P., Aliberti, R., Amoroso, A., An, M.R., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Batozskaya, V., Begzsuren, K., Berger, N., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bloms, J., Bortone, A., Boyko, I., Briere, R.A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G.F., Cao, N., Cetin, S.A., Chang, J.F., Chang, T.T., Chang, W.L., Che, G.R., Chelkov, G., Chen, C., Chen, Chao, Chen, G., Chen, H.S., Chen, M.L., Chen, S.J., Chen, S.M., Chen, T., Chen, X.R., Chen, X.T., Chen, Y.B., Chen, Y.Q., Chen, Z.J., Cheng, W.S., Choi, S.K., Chu, X., Cibinetto, G., Coen, S.C., Cossio, F., Cui, J.J., Dai, H.L., Dai, J.P., Dbeyssi, A., de Boer, R.E., Dedovich, D., Deng, Z.Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X.X., Ding, Y., Dong, J., Dong, L.Y., Dong, M.Y., Dong, X., Du, S.X., Duan, Z.H., Egorov, P., Fan, Y.L., Fang, J., Fang, S.S., Fang, W.X., Fang, Y., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C.Q., Feng, J.H., Fischer, K., Fritsch, M., Fritzsch, C., Fu, C.D., Fu, Y.W., Gao, H., Gao, Y.N., Gao, Yang, Garbolino, S., Garzia, I., Ge, P.T., Ge, Z.W., Geng, C., Gersabeck, E.M., Gilman, A.

Volltext

MA 07.09 ALK/ROS1/TRK Inhibitor TPX-0005 Effectively Overcomes Clinical Resistance Solvent Front Mutations von Cui, J.J., Zhai, D., Deng, W., Rogers, E., Ung, J., Zhang, X., Zhang, H., Huang, Z., Whitten, J., Lim, J., Li, Y.

Volltext

OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC von Lin, J., Kim, D., Drilon, A., Doebele, R., Lee, J., Zhu, V., Ahn, M., Lim, J., Stopatschinskaja, S., Cui, J.J., Hyman, D., Camidge, R., Ou, S., Shaw, A., Cho, B.C.

Volltext

Effect of Pyramiding Bt and CpTI Genes on Resistance of Cotton to Helicoverpa armigera (Lepidoptera: Noctuidae) Under Laboratory and Field Conditions von Cui, Jinjie, Luo, Junyu, Werf, Wopke Van Der, Ma, Yan, Xia, Jingyuan

Volltext

P3.01-073 TPX-0005 with an EGFR Tyrosine Kinase Inhibitor (TKI) Overcomes Innate Resistance in EGFR Mutant NSCLC von Rosell, R., Karachaliou, N., Cui, J.J., Chaib, I., Berenguer, J., Bratch, J., Li, X., Yang, J., Drozdowskyj, A., Servat, C. Codony, Servat, J. Codony, Giménez-Capitán, A., Viteri, S., Molina-Vila, M., López-Vivanco, G., Vergnenegre, A., Sánchez-Torres, J.M., Provencio, M., De Marinis, F., Passaro, A., Carcereny, E., Reguart, N., Campelo, R. García, Ou, S. Ignatius, Cardona, A., Cao, P.

Volltext

Proacrosin activation mechanisms in capacitated and frozen-thawed boar spermatozoa von Cui, J J, Tian, Y, Liu, Y, Huang, H L, Jin, Y

Volltext

Global diversity and molecular systematics of Wrightoporia s.l. (Russulales, Basidiomycota) von Chen, J J, Cui, B K, Dai, Y C

Volltext

Broadband Ground-Plane Cloak von Liu, R, Ji, C, Mock, J.J, Chin, J.Y, Cui, T.J, Smith, D.R

Volltext

Electromagnetic incremental forming (EMIF): A novel aluminum alloy sheet and tube forming technology von Cui, X.H., Mo, J.H., Li, J.J., Zhao, J., Zhu, Y., Huang, L., Li, Z.W., Zhong, K.

Volltext